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Abstract Growth arrest-specific homeobox (Gax) gene was isolated from rat aorta cDNA library and its expression was largely confined to the cardrovascular trssues Gax gene was rapidly downregulated by platelet-derived growth factor m vascular smooth muscle cells (VSMCs) and overexpressed Gax was reported to reduce the neomtlmal thtckenmg after balloon mJury m vtvo We have demonstrated that angrotensm II (Ang II) sttmulates vascular growth In contrast, we also reported that C-type natrmretrc peptrde (CNP) 1s secreted from vascular endothehal cells to act as a novel endothelmm-derived relaxmg peptrde and mhrbtts vascular growth via cGMP cascade In the present study, we examined the effects of Ang II and CNP on Gax gene expression m VSMCs In quiescent rat aortrc VSMCs, Gax mRNA (2 3 kb) level became neghgrble 6 hours after the addmon of Ang II (10e6 mol/L) The mhlbttorv action of Ana II on Gax mRNA expression (EDSo lo-" moli) was almost lompletely blocked by an AT,R antagonist, CV11974 In contrast, CNP 10m6 mol/L M tgratton and proliferation of VSMCs tn neomtlma are key events for the development of hypertensive vascular compltcation, atherosclerosis and coronary restenostsl-6 In contrast to VSMCs with the contractile phenotype present m the intact media of the vascular wall, m the proliferative neomtimal lesion, VSMCs exhibit the synthetic or embryonic phenotype which is characterized by enhanced prohferative and synthetic actrvittes, reorganizatton of the cytoskeleton, and suppressed contracttle activtty.*-6 Such alternation of phenotyprc and prohferatrve features of VSMCs 1s thought to be modulated by various growth factors and cytokmesrs7-'0 through the convergence of their signaling pathways mto the network of transcrtptton factors which govern the gene expressions and phenotypic diversity of the cells. However, until now the mteraction between growth signals and transcrrptton factors concernmg the prohferatton and differentratton of VSMCs has not been well understood Gax gene was isolated from the adult rat aorta cDNA library and its expression 1s largely confined to the cardiovascular tissues such as the aorta, heart, kidney and lung.rr Gax gene was rapidly downregulated during GO/G1 transition caused by PDGF or serum m cultured VSMCsi * and also downregulated m the rat carotid artery after balloon mJury.1z Recently, microinjected recombtnant Gax pepttde was reported to inhibit mitogen-induced entry into the S phase in VSMCsr3 and also demonstrated that overexpressed Gax reduced neomttmal thickening after balloon mJury.14 These findings all together suggest that Gax possesses the crtttcal role m the growth mhtbrtton of VSMCs We have been mvesttgatmg the growth control of VSMCs by several vasoacttve substances. We and others have demonstrated that Ang II stimulates the growth of VSMCs via the activation of PDGF, transforming growth factor-p, and basic fibroblast growth factor 15 On the other hand, we and others reported that natrmretrc peptides inhibit the VSMC prolrferatron vta guanosme 3' 5'-cyclic monophosphate (cGMP) cascade triggered by the acttvatton of the particulate guanylate cyclase which 1s the natrmrettc pepttde receptor ttself 16-18 We also demonstrated that CNP, the thud member of the natnurettc pepttde family, is secreted from vascular endothehal cells19 and possesses vascular growth mhrbttory action via CNP-specific receptor, ANP-B receptor, highly expressed on VSMCs with the synthetic phenotype 2021 We, thus, indicated that CNP 1s a novel endothelmm-derived relaxing peptide involved m vascular remodeling m hypertension and other cardtovascular diseases, and proposed the existence of the vascular NPS similar to the vascular RAS.22 Previously, we have demonstrated that the antagonistic relationshtp between the NPS and RAS m blood pressure control and blood fluid homeostasts, both as an endocrine system and as a neuropeptide systern. 23 We also reported that the vascular NPS is activated Selected Abbreviations and Acronyms 8-Br-cGMP = &bromoadenosine-cGMP Ang II = angiotensin II ANP = atria1 natriuretic peptide CNP = C-type natriuretic peptide DSF = defined serum-free Gax = growth arrest-specific homeobox gene MAPK = mitogen-activated protein kinase NPS = natriuretic peptide system PCR = polymerase chain reaction PDGF = platelet-derived growth factor RAS = renin-angiotensin system VSMC = vascular smooth muscle cell in proliferative vascular lesions, suppressing further proliferation of VSMCs by antagonizing the action of the vascular RAS.22
In the present study, to elucidate the role of Gax on vascular growth control regulated by the antagonism between the RAS and NPS, we have examined the regulation of the Gax gene expression by Ang II and CNP in VSMCs.
Cell Culture
Methods
Cultured aortic VSMCs were derived from the explants of the thoracic aortae of male Wistar rats as previously reported'4 and were grown in Dulbecco's modified Eagle's medium (DMEM, Flow Laboratories, Inc., Irvine, UK) supplemented with 10% fetal calf serum (FCS) (Hazleton Biologics, Inc., Lenexa, Kan.), 100 units/ml penicillin, and 100 pg/mL streptomycin. VSMCs from 6th to 12th passages were used in the present study.
Stimulation of VSMCs
VSMCs were plated into IO-cm-diameter dishes for collection of RNA. At about 70% confluent, cells were made quiescent by the incubation for 48 hours in DSF medium containing insulin (SX IO -' mol/L), transferrin (5 pg/mL), and ascorbate (0.2 mmol/L).~s Then, the medium was replaced with fresh DSF medium and Ang 11 was added. Cells were incubated for the various times and harvested for RNA isolation. DMEM with 0.5% FCS was used instead of DSF medium in the experiments in which either CNP (Peptide Institute Inc., Osaka, Japan) or 8-Br-cGMP (Sigma Chemical Co) was added.
Northern Blot Analysis
Total RNA from cultured VSMCs was prepared by the acid guanidinium thiocyanate-phenol-chloroform method using TRIzol Reagent (Life Technologies, Inc., Gaithersburg, MD.). RNA (40 pg per lane) was separated on 1.2% E agarose gel and blotted to nylon membrane. g 0.5
The filters were hybridized with the PCR-syn-(II cDNA probe was obtained by cDNA synthesis and the polymerase chain reaction method using the total RNA of mesangial cells derived from Wistar-Kyoto Rats with the sense, 5'-AGA-TGTCCTCCCCGCCAAGC-3', and antisense, 5'.TCCTGGGA ATCTGAACTGTC-3', primers, corresponding to nucleotides 480-499 and 70 I-720 of rat Gax cDNA, I I respectively. The probe was labeled by random-primed synthesis to the specific activity of approximately 1 X 10" cpm/l,g. The filters were hybridized with the "P-labeled probe at 42°C in 50% formamide, 5X SSC, 5~ Denhardt's reagent, SO mmol/L sodium phosphate buffer (pH 6.8), 0.1% SDS and 100 mg/L heat-denatured salmon testis DNA, and washed at 55°C in 0.1 X SSC and 0. I % SDS." Imaging and estimation of Gax mRNA expression were performed using image analyzer BAS 2000 (Fuji Photo Film Co. Ltd., Tokyo, Japan). As a control, glyceraldehyde-3-phosphate dehydrogenase mRNA level was determined as previously reported.26
Statistical Analysis
All results were expressed as mean-tSD with n=3 to 6. Statistical analysis of the data was performed using ANOVA. P<.O5 was considered significant. The experiments presented are the representatives of at least two separate experiments.
Reagents
Human Ang 11 and human CNP were purchased from Peptide institute Inc. 8-Bromo-cGMP was purchased from Sigma Chemical Co. (St. Louis, MO.). CVll974, an active metabolite of TCV-116, was purchased from Peninsula Laboratories Inc. Other reagents were purchased from standard commercial suppliers.
Results

Regulation of Gax mRNA Expression by Ang II
The expression of Gax mRNA was analyzed in rat VSMCs by Northern blot analysis. Gax mRNA of approximately 2.3 kilobases was detected as a single band in quiescent VSMCs using the PCR-synthesized probe (see "Methods"), being consistent with the reported size of Gax mRNA, 2244 bases" (data not shown). To confirm the receptor subtype specificity of the inhibitory action of Ang II on Gax mRNA expression, we examined the effect of angiotensin II type 1 receptor (AT,-R) antagonist, CV11974. As shown in Fig 3, expression. Gax mRNA increased from 3 hours after the stimulation, reaching a maximal level at 12 hours and also showed the tendency to decrease 24 hours after the stimulation. The effects of CNP and 8-Br-cGMP on Gax mRNA augmentation were dose dependent (Fig 5) . Twelve hours after the administration of CNP or 8-BrcGMP, significant increase of Gax mRNA expression was observed by lo-" mol/L of CNP and lo-" to 10-j mol/L of 8-Br-cGMP, respectively. The maximal augmentation of Gax mRNA expression compared with the vehicle administration was l&fold and 2.5fold increases by IO-" mol/L of CNP and 10m3 mol/L of S-Br-cGMP (n=6), respectively.
Next, we examined the effect of ANP-C receptor-specific agonist, C-ANF [4-231. ANP-C receptor is not coupled to guanylate cyclase and is proposed to have a major role in the clearance of natriuretic peptide."' As shown in Fig 6, 10m7 mol/L of C-ANF 14-231 exerted no significant effect on Gax mRNA expression 12 hours after the stimulation.
Interaction of Ang II and CNP on Gax mRNA Expression
To confirm the opposite action of Ang II and CNP on Gax mRNA expression, we examined the effect of the simultaneous administration of Ang II and CNP. As shown in Fig 7, 10 . ' mol/L of CNP attenuated the inhibitory action of Ang II lo-'* to lo-' mol/L on Gax mRNA expression 6 hours after the stimulation. The suppression of Gax mRNA expression caused by loo-'" mol/L of Ang II was reversed approximately 60% by the administration of CNP 10m6 mol/L.
Discussion
The present study demonstrates that Ang II, which possesses the promoting action on proliferation and hypertrophy of VSMCs, potently induced rapid and transient downregulation of Gax mRNA expression. The temporal profile of the downregulation of Gax mRNA expression caused by Ang II was similar to that induced by PDGF and serum." The present study also showed that AT,-R antagonist CV11974 almost completely blocked the inhibitory action of Ang 11 on Gax mRNA expression, suggesting that the effect of Ang II on Gax gene expression is mediated via AT,-R. Ang II exhibits proliferative and hypertrophic effects on VSMCs via Gprotein-coupled AT,-R with multiple signal transduction pathways, including the activation of phospholipase C,28 calcium mobilization,29 the activation of protein ki-a. 3 hours after the stimulation, respectively. Previously, we have demonstrated that Ang II induced the growth of VSMCs, but significant growth stimulation was observed by more than lOmy mol/L of Ang II.16 The reason for the difference of sensitivity to Ang II between Gax expression and DNA synthesis is not known at present. The present and previous studies demonstrated that the suppression of Gax mRNA expression is immediately early event in the cell cycle progression, that is, that occurred at least from 3 hours to 12 hours after the mitogen stimulation, corresponding to the period from GO/G1 transition to Gl/S boundary.40 To achieve further progression of the cell cycle and initiation of DNA synthesis, the participation of other factors should be necessary in addition to the suppression of Gax mRNA expression mechanism. It can be, however, at least said that the suppression of Gax mRNA expression is a highly sensitive marker of growth stimulation of VSMCs.
In contrast to the effect of Ang 11, CNP and S-Br-cGMP upregulated Gax mRNA expression. It has been reported that Gax mRNA expression was dependent on the cell yuiescence, that is, Cax was expressed at low levels in subconfluent, but its mRNA level increased within 8 hours after the cellc are placed in serum-poor medium. 40 We demonstrated herein that CNP upregulated Gax mRNA expression in a similar time course with the serum starvation" in a dose-dependent manner. The administration of S-Br-cGMP mimicked the effect of CNP, and C-ANF 14-231, the specific agonist for ANP-C receptor which is not coupled with guanylate cyclase and exhibits no cGMP genesis by natriuretic peptides in VSMCs,z' exerted no significant effect on Gax mRNA expression. All these results suggest that CNP up-regulates Gax mRNA expression via the activation of cGMP cascade. This is, to our knowledge, the first report that growth inhibitory signals up-regulate the Gax mRNA expression. As we have previously demonstrated, CNP possesses the growth inhibitory effect on VSMCs via cGMP cascade. cGMP has been reported to suppress the proliferation of VSMCs by inhibiting the progression from the Gl into S phase of the cell cycle. -II Indeed, recently we demonstrated that overexpression of CNP in VSMCs by adenovirus system caused the Gl growth arrest of VSMCs, by flow cytometry analysiv and Northern blot analysis for mRNA expressions of cyclins and cyclin-dependent kinases required for the cell cycle progression in GI/S boundary.42 The antiproliferalive action via cGMP pathway may be mediated by Gax, which might control the expressions of the genes regulating Cl/S boundary.
We have proposed the counterregulatory effects of NPS on RAS not only in blood pressure and body fluid homeostasiv through vasorelaxation, diureyis and natriuresis, a.
and inhibition of aldosterone secretion,"',"4 but also in vascular growth control.22 The present study revealed that CNP also exerted the antagonistic effect on Ang II-induced suppression of Gax mRNA expression, suggesting that the antagonistic effect between Ang II and CNP on vascular growth is controlled via the regulation of Gax gene expression. Now we examine the involvement of Gax in the growth control of VSMCs by Ang II and CNP using the antisense oligonucleotide method for Gax gene, as we previously reported.15 Taking these results together, it is indicated that Gax can be involved in the signaling pathway of vascular growth control by Ang II and CNP as a common transcription factor and may act as an intracellular switch for controlling on and off of cell proliferation.
Homeobox gene family is well known to be important in the regulation of organogenesis, body plan formation in embryo and cell differentiation as well as cell proliferation.40 Some homeobox genes contribute to the regulation of both cell proliferation and differentiation. For example, an intestine-specific homeobox gene, Cdx-2, leads to arrest of proliferation and induces enterocyte-specific gene expressions in an undifferentiated intestine cell line, IEC-6 cells.45 Gax is a cardiovascular-specific homeobox gene that participates in the growth inhibition of VSMCs. VSMCs are known to dedifferentiate into the synthetic or embryonic phenotype when they re-enter the cell cycle by mitogen stimulation.8.46,47 Inferring from multiple functions of the homeobox gene family on cell proliferation and differentiation, Gax may take some roles on differentiation of VSMCs as well as the growth inhibitory effect. Indeed, the recent studies demonstrated that overexpression of catalytic domain of cGMP-dependent protein kinase, which is one of the major signaling molecules for the cGMP cascade, leads the alternation of morphology of cultured VSMCs into differentiated phenotype."x In addition, CNP is also reported to stimulate the differentiation of osteoblastic cells via cGMP cascade."" It is, therefore, suggested that CNP may promote not only the growth inhibition but also VSMC differentiation by upregulating Gax gene expression via cGMP cascade. Further study to find target genes of Gax for VSMC differentiation should be required.
Recently, Walsh et al reported that lransfer of Gax gene into VSMCs after balloon injury has been shown to inhibit cell proliferation and neointima formation in vivo.14 For gene therapy against vascular proliferative diseases such 
